Top

Published in:

01-02-2011 | Review Article

Parkinson’s disease in China

Authors: You-yong Tian, Cui-ju Tang, Jie Wu, Jun-shan Zhou

Published in: Neurological Sciences | Issue 1/2011

Abstract

Paralysis agitans was first documented in 1817 by James Parkinson, and therefore the syndrome was named Parkinson’s disease (PD). In fact, as early as more than 2000 years ago, the clinical manifestations of this disease have been described in Chinese medicine classics, such as the “Huangdi Neijing (Yellow Emperor’s Internal Classic)” and “Zhong Zang Jing (Hua’s Zhong Zang Classic).” In recent years, especially in the past 30 years after reform and opening-up, PD has drawn a lot of attention by Chinese scholars. Although great progress in the studies of PD has been made in recent years, the gap between China and western countries still exists. In this review, we concentrate on the main progress made in epidemic characteristics, etiology, diagnosis and management of PD in China.

Zhang ZX, Dong ZH, Román GC (2006) Early descriptions of Parkinson disease in ancient China. Arch Neurol 63:782–784CrossRefPubMed

Li SC, Schoenberg BS, Wang CC et al (1985) A prevalence survey of Parkinson’s disease and other movement disorders in the People’s Republic of China. Arch Neurol 42:655–657PubMed

Shi YM, Wang GQ, Xue GB et al (1987) Study on the prevalence of Parkinson disease in Hongkou district, Shanghai. Zhonghua Liu Xing Bing Xue Za Zhi 8:205–207PubMed

Wang YS, Shi YM, Wu ZY et al (1991) Parkinson’s disease in China. Coordinational group of Neuroepidemiology, PLA. Chin Med J 104:960–964PubMed

Ho SC, Woo J, Lee CM (1989) Epidemiologic study of Parkinson’s disease in Hong Kong. Neurology 39:1314–1318PubMed

Wang SJ, Fuh JL, Teng EL et al (1996) A door-to-door survey of Parkinson’s disease in a Chinese population in Kinmen. Arch Neurol 53:66–71PubMed

Chen RC, Chang SF, Su CL et al (2001) Prevalence, incidence, and mortality of PD: a door-to-door survey in Ilan county, Taiwan. Neurology 57:1679–1686PubMed

Tan LC, Venketasubramanian N, Hong CY et al (2004) Prevalence of Parkinson disease in Singapore: Chinese vs. Malays vs. Indians. Neurology 62:1999–2004PubMed

Zhang ZX, Roman GC, Hong Z et al (2005) Parkinson’s disease in China: prevalence in Beijing, Xian, and Shanghai. Lancet 365:595–597PubMed

10.

Zhang L, Nie ZY, Liu Y et al (2005) The prevalence of PD in a nutritionally deficient rural population in China. Acta Neurol Scand 112:29–35CrossRefPubMed

11.

Tanner CM, Chen B, Wang W et al (1989) Environmental factors and Parkinson’s disease: a case–control study in China. Neurology 39:660–664PubMed

12.

Tanner CM, Chen B, Wang WZ et al (1987) Environmental factors in the etiology of Parkinson’s disease. Can J Neurol Sci 14(3 Suppl):419–423PubMed

13.

Chan DK, Woo J, Ho SC et al (1998) Genetic and environmental risk factors for Parkinson’s disease in a Chinese population. J Neurol Neurosurg Psychiatry 65:781–784CrossRefPubMed

14.

Tan EK, Tan C, Fook-Chong SM et al (2003) Dose-dependent protective effect of coffee, tea, and smoking in Parkinson’s disease: a study in ethnic Chinese. J Neurol Sci 216:163–167CrossRefPubMed

15.

Tan LC, Koh WP, Yuan JM et al (2008) Differential effects of black versus green tea on risk of Parkinson’s disease in the Singapore Chinese Health Study. Am J Epidemiol 67:553–560

16.

Ma L, Zhang L, Gao XH et al (2006) Dietary factors and smoking as risk factors for PD in a rural population in China: a nested case–control study. Acta Neurol Scand 113:278–281CrossRefPubMed

17.

Wakabayashi K, Takahashi H (2007) Pathology of familial Parkinson’s disease. Brain Nerve 59:851–864PubMed

18.

Polymeropoulos MH, Higgins JJ, Golbe LI et al (1996) Mapping of a gene for Parkinson’s disease to chromosome 4q21–q23. Science 274:1197–1199CrossRefPubMed

19.

Chan DK, Mellick G, Cai H et al (2000) The alpha-synuclein gene and Parkinson disease in a Chinese population. Arch Neurol 57:501–503CrossRefPubMed

20.

Hu CJ, Sung SM, Liu H et al (1999) No mutation of G209A in the alpha-synuclein gene in sporadic Parkinson’s disease among Taiwan Chinese. Eur Neurol 41:85–87CrossRefPubMed

21.

Lin JJ, Yueh KC, Chang DC et al (1999) Absence of G209A and G88C mutations in the alpha-synuclein gene of Parkinson’s disease in a Chinese population. Eur Neurol 42:217–220CrossRefPubMed

22.

Tan EK, Chai A, Teo YY et al (2004) Alpha-synuclein haplotypes implicated in risk of Parkinson’s disease. Neurology 62(1):128–131PubMed

23.

Zhao XP, Zheng HM, Xie HJ et al (2004) The alpha-synuclein gene microsatellite polymorphism and lateonset sporadic Parkinson’s disease susceptibility. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 21:339–341PubMed

24.

Fung HC, Chen CM, Hardy J et al (2006) A common genetic factor for Parkinson disease in ethnic Chinese population in Taiwan. BMC Neurol 6:47CrossRefPubMed

25.

An XK, Peng R, Li T et al (2008) LRRK2 Gly2385Arg variant is a risk factor of Parkinson’s disease among Han-Chinese from Mainland China. Eur J Neurol 15:301–305CrossRefPubMed

26.

Chan DK, Ng PW, Mok V et al (2008) LRRK2 Gly2385Arg mutation and clinical features in a Chinese population with early-onset Parkinson’s disease compared to late-onset patients. J Neural Transm 115:1275–1277CrossRefPubMed

27.

Li C, Ting Z, Qin X et al (2007) The prevalence of LRRK2 Gly2835Arg variant in Han Chinese population with Parkinson’s disease. Mov Disord 22:2439–2443CrossRefPubMed

28.

Ross OA, Wu YR, Lee MC et al (2008) Analysis of LRRK2 R1628P as a risk factor for Parkinson’s disease. Ann Neurol 64:88–92CrossRefPubMed

29.

Lu CS, Wu-Chan YH, Van Doeselaar M et al (2008) The LRRK2 Arg1628Pro variant is a risk factor for Parkinson’s disease in the Chinese population. Neurogenetics 9:271–276CrossRefPubMed

30.

Wu T, Zeng Y, Ding X et al (2006) A novel P755L mutation in LRRK2 gene associated with Parkinson’s disease. Neuroreport 17:1859–1862CrossRefPubMed

31.

Hao YX, Zhang J, Fang CP et al (2008) Association of two polymorphisms in ubiquitin carboxy-terminal hydrolase-L1 gene with Parkinson’s disease in Shanghai. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 25:272–275PubMed

32.

Wang J, Zhao CY, Si YM et al (2002) ACT and UCH-L1 polymorphisms in Parkinson’s disease and age of onset. Mov Disord 17:767–771CrossRefPubMed

33.

Xiao Y, Zhang B (2008) Association of the ubiquitin carboxy-terminal hydrolase-L1 genetic polymorphism with the susceptibility of Parkinson’s disease. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 25:586–587PubMed

34.

Zhang ZJ, Burgunder JM, An XK et al (2008) Lack of evidence for association of a UCH-L1 S18Y polymorphism with Parkinson’s disease in a Han-Chinese population. Neurosci Lett 442:200–202CrossRefPubMed

35.

Chan DK, Mok V, Ng PW et al (2008) PARK2 mutations and clinical features in a Chinese population with early-onset Parkinson’s disease. J Neural Transm 115:715–719CrossRefPubMed

36.

Shyu WC, Lin SZ, Chiang MF et al (2005) Early-onset Parkinson’s disease in a Chinese population: 99mTc-TRODAT-1 SPECT, Parkin gene analysis and clinical study. Parkinsonism Relat Disord 11(3):173–180CrossRefPubMed

37.

Wu RM, Bounds R, Lincoln S et al (2005) Parkin mutations and early-onset parkinsonism in a Taiwanese cohort. Arch Neurol 62:82–87CrossRefPubMed

38.

Wu RM, Shan DE, Sun CM et al (2002) Clinical, 18F-dopa PET, and genetic analysis of an ethnic Chinese kindred with early-onset parkinsonism and parkin gene mutations. Mov Disord 17:670–675CrossRefPubMed

39.

Tan EK, Puong KY, Chan DK et al (2005) Impaired transcriptional upregulation of Parkin promoter variant under oxidative stress and proteasomal inhibition: clinical association. Hum Genet 118:484–488CrossRefPubMed

40.

Taylor JM, Wu RM, Lin CH et al (2009) Lack of evidence for association of a parkin promoter polymorphism with early-onset Parkinson’s disease in a Chinese population. Parkinsonism Relat Disord 15:149–152CrossRefPubMed

41.

Peng R, Gou Y, Yuan Q et al (2003) Mutation screening and association analysis of the parkin gene in Parkinson’s disease patients from South-West China. Eur Neurol 49:85–89CrossRefPubMed

42.

Wang F, Chen B, Feng XL et al (2007) PINK1 IVS5–5 G>A polymorphism may contribute to the risk of late onset Parkinson disease in Chinese. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 24:305–309PubMed

43.

Wang F, Feng X, Ma J et al (2006) A common A340T variant in PINK1 gene associated with late-onset Parkinson’s disease in Chinese. Neurosci Lett 410:121–125CrossRefPubMed

44.

Chan DK, Mellick GD, Buchanan DD et al (2002) Lack of association between CYP1A1 polymorphism and Parkinson’s disease in a Chinese population. J Neural Transm 109:35–39CrossRefPubMed

45.

Wang J, Liu Z, Chan P (2000) Lack of association between cytochrome P450 2E1 gene polymorphisms and Parkinson’s disease in a Chinese population. Mov Disord 15:1267–1269CrossRefPubMed

46.

Chan DK, Lam MK, Wong R et al (2003) Strong association between N-acetyltransferase 2 genotype and PD in Hong Kong Chinese. Neurology 60:1002–1005PubMed

47.

Lee CG, Tang K, Cheung YB et al (2004) MDR1, the blood-brain barrier transporter, is associated with Parkinson’s disease in ethnic Chinese. J Med Genet 41:e60CrossRefPubMed

48.

Tang G, Zhang M, Xie H et al (2002) Alpha-2 macroglobulin I1000 V polymorphism in Chinese sporadic Alzheimer’s disease and Parkinson’s disease. Neurosci Lett 328:195–197CrossRefPubMed

49.

Tang G, Xie H, Xu L et al (2002) Genetic study of apolipoprotein E gene, alpha-1 antichymotrypsin gene in sporadic Parkinson disease. Am J Med Genet 114:446–449CrossRefPubMed

50.

Jiang G, Xu L, Wang L et al (2008) Association study of human MTH1 Ile45Thr polymorphism with sporadic Parkinson’s disease. Eur Neurol 59:15–17CrossRefPubMed

51.

Han Y, Zhang XH, Chen T et al (2008) The survey for the diagnosis and treatment of Parkinson’s disease. Zhonghua Bao Jian Yi Xue Za Zhi 10:18–20

52.

Zhang ZX (The Group of Movement disorders and Parkinson’s disease, Neurologic Branch of Chinese Medical Association) (2006) The diagnosis of Parkinson’s disease. Zhonghua Shen Jing Ke Za Zhi 39: 408–409

53.

Feng F, You H, Wang H et al (2009) Phase-weighted imaging in differentiating multiple system atrophy from idiopathic Parkinson disease. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 31:129–133PubMed

54.

Chen SD (The Group of Movement Disorders and Parkinson’s Disease, Neurologic Branch of Chinese Medical Association) (2006) The guideline for management of Parkinson’s disease. Zhonghua Shen Jing Ke Za Zhi 39:409–412

55.

Wang X, Liang XB, Li FQ et al (2008) Therapeutic strategies for Parkinson’s disease: the ancient meets the future—traditional Chinese herbal medicine, electroacupuncture, gene therapy and stem cells. Neurochem Res 33:1956–1963CrossRefPubMed

56.

Li JY, Yang MH, Dou YQ et al (2008) TCM therapy for Parkinson’s disease. Beijing Zhong Yi Xue Za Zhi 27:300–302

57.

Ren XM (2008) Fifty cases of Parkinson’s disease treated by acupuncture combined with madopar. J Tradit Chin Med 28:255–257CrossRefPubMed

58.

Liang XB, Liu XY, Li FQ et al (2002) Long-term high-frequency electro-acupuncture stimulation prevents neuronal degeneration and up-regulates BDNF mRNA in the substantia nigra and ventral tegmental area following medial forebrain bundle axotomy. Brain Res Mol Brain Res 108:51–59CrossRefPubMed

59.

Lam YC, Kum WF, Durairajan SS et al (2008) Efficacy and safety of acupuncture for idiopathic Parkinson’s disease: a systematic review. J Altern Complement Med 14:663–671CrossRefPubMed

60.

Sun B, Lang LQ, Cong PY et al (2001) History of Chinese stereotactic and functional neurosurgery. Stereotact Funct Neurosurg 717:17–19CrossRef

61.

Iacono RP, Tang ZS, Mazziotta JC et al (1992) Bilateral fetal grafts for Parkinson’s disease: 22 months’ results. Stereotact Funct Neurosurg 58:84–87CrossRefPubMed

62.

Liu J, Huang HY (2007) How to improve the survival of the fetal ventral mesencephalic cell transplanted in Parkinson’s disease? Neurosci Bull 23:377–382CrossRefPubMed

63.

Zhang ZX, Anderson DW, Huang JB et al (2003) Prevalence of Parkinson’s disease and related disorders in the elderly population of greater Beijing, China. Mov Disord 18:764–772CrossRefPubMed

64.

Woo J, Lau E, Ziea E et al (2004) Prevalence of Parkinson’s disease in a Chinese population. Acta Neurol Scand 109:228–231CrossRefPubMed

Title: Parkinson’s disease in China
Authors: You-yong Tian
Cui-ju Tang
Jie Wu
Jun-shan Zhou
Publication date: 01-02-2011
Publisher: Springer Milan
Published in: Neurological Sciences / Issue 1/2011
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-010-0461-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Parkinson’s disease in China

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2011

Vitamin B12 deficiency associated with symptoms of frontotemporal dementia

The effect of lentivirus-mediated TH and GDNF genetic engineering mesenchymal stem cells on Parkinson’s disease rat model

Potential relevance of low-intensity microembolic signals by TCD monitoring

Pursuit ocular movements in multiple sclerosis: a video-based eye-tracking study

Chronic cerebro-spinal venous insufficiency (CCSVI) and multiple sclerosis

Role of glial cells in neurotoxin-induced animal models of Parkinson’s disease